Navigation Links
CSL Behring Marks World Hemophilia Day by Announcing the Winners of the 'CSL Behring - Prof. Heimburger Award 2011'
Date:4/15/2011

mpson, Rush University Medical Center, Chicago, Illinois, USA.
  • Thrombin and plasmin generation capacity as predictors of joint outcomes in children with severe hemophilia A
  • Chee Wee Tan, Northern Blood Research Centre, University of Sydney, Australia.
    • Effect of factor Xa, thrombin and new anticoagulants on human platelet glycoprotein VI (GPVI) expression and GPVI-mediated coagulation
    • Impact on hemostasis of acute and chronic air pollution by particulate matter
  • Janine Eliza van Loon, Erasmus Medical Center, Rotterdam, The Netherlands.
    • Role of snare protein genes in the regulation of von Willebrand Factor levels and bleeding phenotype in patients with type I von Willebrand disease

  • The CSL Behring – Prof. Heimburger Award is a worldwide initiative inspired by CSL Behring's passionate commitment to innovation and research in order to provide the best possible therapies and services to everyone.

    Speaking at this year's CSL Behring – Prof. Heimburger Award Symposium, CSL Behring's Executive Vice President of Worldwide Commercial Operations, Paul Perreault, congratulated all award recipients. "We are privileged and honored to be so involved with the bleeding disorders community through the young investigators recognized by the Prof. Heimburger Award," he said. "It is the quality of the basic science that ultimately translates into patient benefits. We must make sure we have strong future leaders in this field."

    Applications for the CSL Behring – Prof. Heimburger 2012 Award will close on October 7, 2011. More information about the award and specific criteria for 2012 applications can be found at: www.cslbehring.
    '/>"/>

    SOURCE CSL Behring
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. Video: CSL Behring Provides $1.2M Grant for Worlds First Study of Postpartum Women with VWD, Common Bleeding Disorder
    2. CSL Behrings Innovative HeliTrax(SM) System Helps Physicians Manage Hemophilia A Patients
    3. ProFibrix and CSL Behring Enter Into Fibrinogen and Thrombin Supply Agreement
    4. CSL Behring Awards Advocacy Grants to Patient Groups in Maryland, New England, the Midwest and Washington
    5. Fifth DuraHeart(TM) U.S. Implant Marks Important Milestone in U.S. Pivotal Trial
    6. Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks
    7. Ernst & Young Benchmarks Danish Biotech Pipeline Third in Europe
    8. CPA Global Marks 40th Anniversary With Launch of New Brand
    9. 2009 Marks 50 Years of Innovative Firsts for Instrumentation Laboratory
    10. New Study Provides Benchmarks for Winning Brand Team Management
    11. New Study Provides Benchmarks for Optimizing Marketing Staff Levels to Drive Growth
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... 2014 The Microcompetition with Foreign DNA ... disease. One of these latent viruses is the Epstein ... rheumatoid arthritis (RA). Rheumatoid arthritis (RA) is a chronic ... by the theory, a study found that RA patients ... (1). , What is Microcompetition? , Dr. Hanan ...
    (Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... of high throughput research solutions, today announced that ... companies, has received delivery of Freeslate’s CM ... form screening. , Lupin, headquartered in Mumbai, ... quality, affordable generic and branded formulations and Active ...
    (Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, ... Foundation, the only national nonprofit organization solely dedicated to ... quality of life for those affected worldwide, will host ... Warrington Country Club in Warrington, Pa. , Each ...
    (Date:1/14/2014)... , Jan. 14, 2014  3D Communications, a leading provider ... major scientific, regulatory, business, and media events in ... , today announced its former associate Virginia Cox , ... office. Virginia Cox re-joins ... Commissioner for the Office of External Affairs at the U.S. ...
    Breaking Biology Technology:Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Former FDA Associate Commissioner Returns To 3D Communications 2
    ... Calif., Jan. 5 Beckman Coulter, Inc. (NYSE: ... and marketer of products that simplify, automate, and ... Garrett, Beckman Coulter,s chairman, president and chief executive ... Morgan Healthcare Conference on Monday, January 12, 2009 ...
    ... - YM BioSciences Inc. (NYSE Alternext US:YMI, ... develops and commercializes differentiated products for patients ... clearance from Canadian regulatory authorities to initiate ... nimotuzumab, its EGFR-targeting antibody, in combination with ...
    ... and Development of Anti-Inflammatory Drugs Based on Collaborators, ... Jan. 5 Research published in Nature ... interactions between two small signaling proteins called chemokines ... development of atherosclerosis in mice. San Diego-based Carolus ...
    Cached Biology Technology:YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 2YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 3YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 4YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 5YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 6YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG CANCER 7Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice 2Research Published in Nature Medicine Shows Disruption of Chemokine Interactions Inhibits Atherosclerosis in Mice 3
    (Date:4/15/2014)... Biologists at UC San Diego have succeeded in ... hormone responsible for growth and resistance to drought. ... studies to determine how the hormone helps plants ... by the continuing increase in the atmosphere,s carbon ... achievement appears in the April 15 issue of ...
    (Date:4/15/2014)... have found a less invasive way to extract ... study how the mouth,s natural defenses ward off ... immune cells (white blood cells known as "leukocytes") ... mouthor reject foreign tissues, such as in failed ... and preventing such health issues as oral cancers, ...
    (Date:4/15/2014)... (KNAW) has announced the names of five internationally renowned ... million US dollars prize money in total). The laureates ... science. , This year marks the 50th anniversary of ... Erwin Chargaff in 1964. , KNAW juries have ... , Christopher M. Dobson, John Humphrey Plummer ...
    Breaking Biology News(10 mins):Biologists develop nanosensors to visualize movements and distribution of plant hormone 2New method isolates immune cells for researchers to study how they ward off oral diseases 2Five scientists awarded prestigious Heineken Prizes 2
    ... are the surprising culprits in delivering pollutants ?through their ... study shows. , The most common form of wildlife ... of the human-made contaminants to some coastal ecosystems, the ... pollutants such as mercury and DDT to as much ...
    ... discovered a novel way in which the brain size ... a signaling pathway that controls the orientation in which ... The way these cells are sliced during development is ... gives rise to two mature neurons that are incapable ...
    ... begun to clarify how one of the body's molecules controls ... and on to tissues to fight infection -- a crucial ... and causing autoimmune diseases. , The traffic control system -- ... on T cells -- usually prevents T cells from launching ...
    Cached Biology News:Industrial contaminants spread by seabirds in High Arctic, new Canadian study shows 2Brain size may depend upon how neural cells are cleaved 2Brain size may depend upon how neural cells are cleaved 3Discovery of T-cell 'traffic control' boosts new drug promise 2Discovery of T-cell 'traffic control' boosts new drug promise 3Discovery of T-cell 'traffic control' boosts new drug promise 4
    ... coli containing a clone of the human Topoisomerase ... II alters the topological state of nucleic acids ... transient break which generates a separate DNA helix ... DNA passage mechanism, the enzyme can relax negatively ...
    RNase-Free DNase 50 l...
    supplied with 10x reaction buffer...
    ... RNase H degrades, as an endoribonuclease, ... DNA hybrids of natural origin, e.g. ... synthetic complexes, e.g. poly(A) x poly(dT). ... and 3-OH termini. Nearly no activity ...
    Biology Products: